A Phase II study of continuous infusion 5-fluorouracil in advanced hormone refractory prostate cancer: an Illinois cancer center study
- PMID: 8111726
- DOI: 10.1002/1097-0142(19940301)73:5<1536::aid-cncr2820730538>3.0.co;2-1
A Phase II study of continuous infusion 5-fluorouracil in advanced hormone refractory prostate cancer: an Illinois cancer center study
Comment on
-
A phase II study of continuous infusion 5-fluorouracil in advanced hormone refractory prostate cancer. An Illinois Cancer Center Study.Cancer. 1993 Sep 15;72(6):1965-8. doi: 10.1002/1097-0142(19930915)72:6<1965::aid-cncr2820720629>3.0.co;2-x. Cancer. 1993. PMID: 8364875 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical